Heidi A Hanson1,2, Kevin P Horn3, Kelli M Rasmussen3, John M Hoffman3, Ken R Smith1,4. 1. Population Sciences, Huntsman Cancer Institute. 2. Department of Family and Preventive Medicine, University of Utah, Salt Lake City. 3. Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, Utah. 4. Department of Family and Consumer Studies, University of Utah, Salt Lake City.
Abstract
OBJECTIVE: Several studies have suggested that cancer is associated with a reduced risk of the development of Alzheimer's disease (AD). This study seeks to improve our understanding of the association between cancer and the development of AD by showing how mortality selection alters this relationship. METHOD: A retrospective cohort study was carried out examining 92,425 individuals (47,873 women and 44,552 men) from the Utah Population Database with and without a history of any primary cancer identified by the Utah Cancer Registry. All individuals were aged 65-79 years and free of dementia in 1992 and followed for upwards of 18 years (1992-2009) for AD ascertainment, which was identified using diagnostic information from Medicare claims data. RESULTS: We replicate previous results suggesting that cancer is associated with reduced risk of subsequent AD under specific statistical model specifications. However, these results should not be interpreted as evidence of an etiological association. We conclude that higher rates of overall mortality among individuals with cancer relative to those without cancer induce the widely reported putative protective association with cancer. CONCLUSION: Careful consideration of model specification and the profound effects of mortality selection in the older adult population is essential when investigating the relationship between aging-related diseases such as cancer and AD. We show that cancer does not provide protection from AD as previously described in the literature. Social scientists seeking to understand social disparities in disease outcomes among older adults may therefore want to strongly consider the role of mortality selection which, if uncorrected, may generate biased associations.
OBJECTIVE: Several studies have suggested that cancer is associated with a reduced risk of the development of Alzheimer's disease (AD). This study seeks to improve our understanding of the association between cancer and the development of AD by showing how mortality selection alters this relationship. METHOD: A retrospective cohort study was carried out examining 92,425 individuals (47,873 women and 44,552 men) from the Utah Population Database with and without a history of any primary cancer identified by the Utah Cancer Registry. All individuals were aged 65-79 years and free of dementia in 1992 and followed for upwards of 18 years (1992-2009) for AD ascertainment, which was identified using diagnostic information from Medicare claims data. RESULTS: We replicate previous results suggesting that cancer is associated with reduced risk of subsequent AD under specific statistical model specifications. However, these results should not be interpreted as evidence of an etiological association. We conclude that higher rates of overall mortality among individuals with cancer relative to those without cancer induce the widely reported putative protective association with cancer. CONCLUSION: Careful consideration of model specification and the profound effects of mortality selection in the older adult population is essential when investigating the relationship between aging-related diseases such as cancer and AD. We show that cancer does not provide protection from AD as previously described in the literature. Social scientists seeking to understand social disparities in disease outcomes among older adults may therefore want to strongly consider the role of mortality selection which, if uncorrected, may generate biased associations.
Authors: Yi-Ju Li; William K Scott; Dale J Hedges; Fengyu Zhang; P Craig Gaskell; Martha A Nance; Ray L Watts; Jean P Hubble; William C Koller; Rajesh Pahwa; Matthew B Stern; Bradley C Hiner; Joseph Jankovic; Fred A Allen; Christopher G Goetz; Frank Mastaglia; Jeffrey M Stajich; Rachel A Gibson; Lefkos T Middleton; Ann M Saunders; Burton L Scott; Gary W Small; Kristin K Nicodemus; Allison D Reed; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Michael Conneally; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance Journal: Am J Hum Genet Date: 2002-03-01 Impact factor: 11.025
Authors: Elizabeth O'Brien; Richard Kerber; Ken Smith; Geraldine Mineau; Ken Boucher; Diana Lane Reed Journal: J Gerontol A Biol Sci Med Sci Date: 2007-08 Impact factor: 6.053
Authors: Jane A Driver; Alexa Beiser; Rhoda Au; Bernard E Kreger; Greta Lee Splansky; Tobias Kurth; Douglas P Kiel; Kun Ping Lu; Sudha Seshadri; Phillip A Wolf Journal: BMJ Date: 2012-03-12
Authors: Laura Frain; David Swanson; Kelly Cho; David Gagnon; Kun Ping Lu; Rebecca A Betensky; Jane Driver Journal: Alzheimers Dement Date: 2017-07-12 Impact factor: 21.566
Authors: Anne G Ording; Erzsébet Horváth-Puhó; Katalin Veres; M Maria Glymour; Mikael Rørth; Henrik T Sørensen; Victor W Henderson Journal: Alzheimers Dement Date: 2020-05-20 Impact factor: 21.566
Authors: Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-25 Impact factor: 4.254
Authors: Apar Gupta; Sarah R Preis; Alexa S Beiser; Greta L Splansky; Charles S DeCarli; Rhoda Au; Jane A Driver Journal: Adv Geriatr Med Res Date: 2019-07-04
Authors: Danielle Klinger; Brian L Hill; Noam Barda; Eran Halperin; Ofer N Gofrit; Charles L Greenblatt; Nadav Rappoport; Michal Linial; Hervé Bercovier Journal: Vaccines (Basel) Date: 2021-05-11